11-2131311-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP5BP4BA1
The NM_000612.6(IGF2):c.*1676G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.711 in 233,194 control chromosomes in the GnomAD database, including 59,598 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in Lovd as Likely pathogenic (no stars).
Frequency
Genomes: 𝑓 0.72 ( 40323 hom., cov: 34)
Exomes 𝑓: 0.69 ( 19275 hom. )
Consequence
IGF2
NM_000612.6 3_prime_UTR
NM_000612.6 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0910
Genes affected
IGF2 (HGNC:5466): (insulin like growth factor 2) This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PP5
Variant 11-2131311-C-G is Pathogenic according to our data. Variant chr11-2131311-C-G is described in Lovd as [Likely_pathogenic].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95). . Strength limited to SUPPORTING due to the PP5.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.774 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGF2 | NM_000612.6 | c.*1676G>C | 3_prime_UTR_variant | 4/4 | ENST00000416167.7 | NP_000603.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGF2 | ENST00000416167 | c.*1676G>C | 3_prime_UTR_variant | 4/4 | 1 | NM_000612.6 | ENSP00000414497.2 | |||
IGF2 | ENST00000381406 | c.*1676G>C | 3_prime_UTR_variant | 4/4 | 2 | ENSP00000370813.4 | ||||
IGF2 | ENST00000381395 | c.*1676G>C | 3_prime_UTR_variant | 4/4 | 2 | ENSP00000370802.1 |
Frequencies
GnomAD3 genomes AF: 0.724 AC: 110179AN: 152094Hom.: 40275 Cov.: 34
GnomAD3 genomes
AF:
AC:
110179
AN:
152094
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.687 AC: 55601AN: 80982Hom.: 19275 Cov.: 0 AF XY: 0.686 AC XY: 25555AN XY: 37236
GnomAD4 exome
AF:
AC:
55601
AN:
80982
Hom.:
Cov.:
0
AF XY:
AC XY:
25555
AN XY:
37236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.725 AC: 110289AN: 152212Hom.: 40323 Cov.: 34 AF XY: 0.721 AC XY: 53645AN XY: 74398
GnomAD4 genome
AF:
AC:
110289
AN:
152212
Hom.:
Cov.:
34
AF XY:
AC XY:
53645
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at